Meta-analysis on efficacy of statins for prevention of contrast-induced acute kidney injury in patients undergoing coronary angiography

American Journal of Cardiology

Volumn 114, Issue 9, 2014, Pages 1295-1302

  Ukaigwe, Anene ^a   Karmacharya, Paras ^a   Mahmood, Maryam ^a   Pathak, Ranjan ^a   Aryal, Madan Raj ^a   Jalota, Leena ^a   Donato, Anthony A ^a  

^a Reading Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CONTRAST MEDIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ROSUVASTATIN; SIMVASTATIN;

ACUTE KIDNEY FAILURE; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CREATININE CLEARANCE; DIABETES MELLITUS; DRUG EFFICACY; DRUG MEGADOSE; HEART CATHETERIZATION; HUMAN; HYDROPHILICITY; KIDNEY FAILURE; LOW DRUG DOSE; META ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; ACUTE KIDNEY INJURY; CHEMICALLY INDUCED; CORONARY ARTERY DISEASE; RADIOGRAPHY; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; TREATMENT OUTCOME;

EID: 84908066776     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2014.07.059     Document Type: Article

References (27)

1. S. Acikel, H. Muderrisoglu, A. Yildirir, A. Aydinalp, E. Sade, N. Bayraktar, U. Bal, and B. Ozin Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography Blood Coagul Fibrinolysis 21 2010 750 757
2. S.-H. Jo, B.-K. Koo, J.-S. Park, H.-J. Kang, Y.-S. Cho, Y.-J. Kim, T.-J. Youn, W.-Y. Chung, I.-H. Chae, D.-J. Choi, D.-W. Sohn, B.-H. Oh, Y.-B. Park, Y.-S. Choi, and H.-S. Kim Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial - a randomized controlled study Am Heart J 155 2008 499.e1 499.e8
3. W. Li, X. Fu, Y. Wang, X. Li, Z. Yang, X. Wang, W. Geng, X. Gu, G. Hao, Y. Jiang, W. Fan, W. Wu, and S. Li Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention Cardiology 122 2012 195 202
4. A. Toso, M. Maioli, M. Leoncini, M. Gallopin, D. Tedeschi, C. Micheletti, C. Manzone, M. Amato, and F. Bellandi Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease Am J Cardiol 105 2010 288 292
5. J. Xinwei, F. Xianghua, Z. Jing, G. Xinshun, X. Ling, F. Weize, H. Guozhen, J. Yunfa, W. Weili, and L. Shiqiang Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention Am J Cardiol 104 2009 519 524
6. X. Zhou, Y. Jin, Q. Wang, R. Min, and X. Zhang Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography Zhonghua Xin Xue Guan Bing Za Zhi 37 2009 394 396
7. H. Ozhan, I. Erden, S. Ordu, M. Aydin, O. Caglar, C. Basar, S. Yalcin, and R. Alemdar Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography Angiology 61 2010 711 714
8. C. Quintavalle, D. Fiore, F. De Micco, G. Visconti, A. Focaccio, B. Golia, B. Ricciardelli, E. Donnarumma, A. Bianco, M.A. Zabatta, G. Troncone, A. Colombo, C. Briguori, and G. Condorelli Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury Circulation 126 2012 3008 3016
9. R. Pappy, S. Stavrakis, T.A. Hennebry, and M.S. Abu-Fadel Effect of statin therapy on contrast-induced nephropathy after coronary angiography: a meta-analysis Int J Cardiol 151 2011 348 353
10. H. Takagi, and T. Umemoto A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy Int J Cardiol 153 2011 323 325
11. B.-C. Zhang, W.-M. Li, and Y.-W. Xu High-dose statin pretreatment for the prevention of contrast-induced nephropathy: a meta-analysis Can J Cardiol 27 2011 851 858
12. T. Zhang, L.-H. Shen, L.-H. Hu, and B. He Statins for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Nephrol 33 2011 344 351
13. Y. Li, Y. Liu, L. Fu, C. Mei, and B. Dai Efficacy of short-term high-dose statin in preventing contrast-induced nephropathy: a meta-analysis of seven randomized controlled trials PloS One 7 2012 e34450
14. M. Leoncini, A. Toso, M. Maioli, F. Tropeano, S. Villani, and F. Bellandi Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome) J Am Coll Cardiol 63 2014 71 79
15. Y. Han, G. Zhu, L. Han, F. Hou, W. Huang, H. Liu, J. Gan, T. Jiang, X. Li, W. Wang, S. Ding, S. Jia, W. Shen, D. Wang, L. Sun, J. Qiu, X. Wang, Y. Li, J. Deng, J. Li, K. Xu, B. Xu, R. Mehran, and Y. Huo Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease J Am Coll Cardiol 63 2014 62 70
16. P.A. McCullough Contrast-induced acute kidney injury J Am Coll Cardiol 51 2008 1419 1428
17. J. Lin, L.-R. Hong, and Y. Qiu Clinical research of atorvastatin on preventing contrast-induced nephropathy in patients underwent coronary artery CTA [in Chinese] Clin Med Eng 17 2010 48 50
18. G. Patti, E. Ricottini, A. Nusca, G. Colonna, V. Pasceri, A. D'Ambrosio, A. Montinaro, and G. Di Sciascio Short-term, high-dose atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty - contrast-induced nephropathy] trial Am J Cardiol 108 2011 1 7
19. K. Nash, A. Hafeez, and S. Hou Hospital-acquired renal insufficiency Am J Kidney Dis 39 2002 930 936
20. A. Verhulst, P.C. D'Haese, and M.E. De Broe Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells J Am Soc Nephrol 15 2004 2249 2257
21. M. Leoncini, A. Toso, M. Maioli, F. Tropeano, and F. Bellandi Statin treatment before percutaneous coronary intervention J Thorac Dis 5 2013 335 342
22. R.P. Mason, M.F. Walter, C.A. Day, and R.F. Jacob Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions Am J Cardiol 96 2005 11F 23F
23. R. Mehran, E.D. Aymong, E. Nikolsky, Z. Lasic, I. Iakovou, M. Fahy, G.S. Mintz, A.J. Lansky, J.W. Moses, G.W. Stone, M.B. Leon, and G. Dangas A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation J Am Coll Cardiol 44 2004 1393 1399
24. M.A. Alpert Do statins reduce the risk of contrast-induced acute kidney injury in patients undergoing coronary angiography or percutaneous coronary interventions? J Am Coll Cardiol 63 2014 80 82
25. Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) European Association for Percutaneous Cardiovascular Interventions (EAPCI) W. Wijns, P. Kolh, N. Danchin, C. Di Mario, V. Falk, T. Folliguet, S. Garg, K. Huber, S. James, J. Knuuti, J. Lopez-Sendon, J. Marco, L. Menicanti, M. Ostojic, M.F. Piepoli, C. Pirlet, J.L. Pomar, N. Reifart, F.L. Ribichini, M.J. Schalij, P. Sergeant, P.W. Serruys, S. Silber, M. Sousa Uva, and D. Taggart Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555
26. M.S. Hasan, H.B. Basri, L.P. Hin, and J. Stanslas Genetic polymorphisms and drug interactions leading to clopidogrel resistance: why the Asian population requires special attention Int J Neurosci 123 2013 143 154
27. A.F. Manini, B. Stimmel, and D. Vlahov Racial susceptibility for QT prolongation in acute drug overdoses J Electrocardiol 47 2014 244 250